98%
921
2 minutes
20
Several epidemiological models have been proposed to study the evolution of COVID-19 pandemic. In this paper, we propose an extension of the SUIHTER model, to analyse the COVID-19 spreading in Italy, which accounts for the vaccination campaign and the presence of new variants when they become dominant. In particular, the specific features of the variants (e.g. their increased transmission rate) and vaccines (e.g. their efficacy to prevent transmission, hospitalization and death) are modeled, based on clinical evidence. The new model is validated comparing its near-future forecast capabilities with other epidemiological models and exploring different scenario analyses.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906164 | PMC |
http://dx.doi.org/10.1016/j.idm.2022.03.002 | DOI Listing |
Overview: We analysed Australian Immunisation Register (AIR) data, predominantly for National Immunisation Program funded vaccines, as at 2 April 2023 for children, adolescents and adults, focusing on the calendar year 2022 and on trends from previous years. This report aims to provide comprehensive analysis and interpretation of vaccination coverage data to inform immunisation policy and programs.
Children: Fully vaccinated coverage in Australian children in 2022 was 0.
Vaccine
September 2025
Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia; Sydney Infectious Diseases Institute, Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia. Electronic address:
Background/objectives: The importance of pro-equity strategies in addressing disadvantages that people and communities face due to their gender, migration status, ethnicity, disability, and place of residence is increasingly being recognised, but analysis of empirical evidence on how they improve vaccination in these priority groups is limited. This systematic review aims to fill this gap.
Methods: Standard evidence synthesis methods were employed, with searches conducted in four major bibliographic databases in March 2025.
JCO Glob Oncol
May 2025
Department of Obstetrics and Gynaecology, Stanford University School of Medicine, Stanford, CA.
Purpose: Expanding high-risk human papillomavirus (HPV) vaccine coverage in resource-constrained settings is critical to bridging the cervical cancer gap and achieving the global action plan for elimination. Mobile health (mHealth) technology via short message services (SMS) has the potential to improve HPV vaccination uptake. The mHealth-HPVac study evaluated the effectiveness of mHealth interventions in increasing HPV vaccine uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria.
View Article and Find Full Text PDFHealth Commun
September 2025
College of Journalism and Communications, University of Florida.
As family communication is significantly related to individuals' health decision-making, it is crucial to tap into the power of this relationship for public health initiatives. The COVID-19 pandemic provided a ripe context in which to explore whether vaccination messaging could be tailored in such a way as to target specific family communication climates to encourage vaccine promotion among family members. Specifically, our study ( = 1,276) designed pro-vaccination messaging tailored based on two types of family communication styles.
View Article and Find Full Text PDFFront Public Health
September 2025
Directorate-General of Health (DGS), Lisbon, Portugal.
Background: Seasonal vaccination campaigns against influenza and COVID-19 are critical for protecting vulnerable populations. Scientific evidence on past campaigns is essential for the effectiveness of future campaigns. This study aims to: (1) assess predictors of influenza and COVID-19 vaccination intentions (2) explore perceived barriers and facilitators of 2023-2024 seasonal vaccination campaign.
View Article and Find Full Text PDF